PRECONDITIONING EFFECT OF INALATORY ANESTHETICS

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2004-004723-35-IT

Enrollment

160

Registered

2005-02-15

Start date

2005-01-27

Completion date

Unknown

Last updated

2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SEVOFLURANE USED AS ANESTETIC IN ORDER TO OBTAIN A MYOCARDIAL PROTECTION MedDRA version: 14.1 Level: SOC Classification code 10042613 Term: Surgical and medical procedures System Organ Class: 10042613 - Surgical and medical procedures

Interventions

Trade Name: SEVORANE*INAL 250ML QUIK FIL Pharmaceutical Form: Pressurised inhalation, solution INN or Proposed INN: Sevoflurane CAS Number: 28523-86-6 Concentration unit: mg milligram(s) Concentration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: 0 F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Italy

Contacts

Public ContactAnestesia e Rianimazione

Ospedale San Raffaele IRCCS

landoni.giovanni@hsr.it0226437176

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026